MedTrace Logo

Resistance Inspiratory Muscle Training for Patients With Thoracic Malignancies

NCT03834116 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 196

Last updated 2022-08-23

No results posted yet for this study

Summary

A small-scale pilot randomized controlled trial conducted by the investigators demonstrated some preliminary evidence that inspiratory muscle training (IMT) could be a promising self-management method for alleviating breathlessness. Hence, the aim of this study is to assess the effectiveness of IMT in patients with thoracic malignancies on dyspnea.

Conditions

  • Lung Neoplasm Malignant

Interventions

DEVICE

Inspiratory muscle training

A pressure threshold device will be used to deliver IMT, which is commercially available by Phillips Respironics.

Sponsors & Collaborators

  • The Affiliated Hospital Of Southwest Medical University

    collaborator OTHER

  • The Hong Kong Polytechnic University

    lead OTHER

Principal Investigators

  • Alex Molassiotis · The Hong Kong Polytechnic University

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
PARALLEL

Eligibility

Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2019-11-23
Primary Completion
2021-09-15
Completion
2021-09-15

Countries

  • China

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03834116 on ClinicalTrials.gov